RecruitingPhase 3NCT07674654
A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine
Sponsor: Kallyope Inc.
Austin, TX · Cypress, TX · +110 more sites
Clinical trials in Waxahachie, TX
8 recruiting studies have a site in or near Waxahachie, TX, Texas.
Top conditions here
All conditions
- Alzheimer's Disease
- Asthma
- Breast Cancer
- COPD
- Crohn's Disease
- Depression
- Type 1 Diabetes
- Type 2 Diabetes
- Heart Failure
- Hypertension
- Leukemia
- Lung Cancer
- Lupus
- Migraine
- Multiple Sclerosis
- Obesity
- Parkinson's Disease
- Prostate Cancer
- Psoriasis
- Rheumatoid Arthritis
- Schizophrenia
- Sickle Cell Disease
- Ulcerative Colitis
- Colorectal Cancer
Showing 8 of 8 studies
RecruitingPhase 3NCT06810505
A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
Sponsor: AbbVie
Austin, TX · Houston, TX · Waxahachie, TX · +29 more sites
RecruitingPhase 3NCT05711394
A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine
Sponsor: AbbVie
Austin, TX · El Paso, TX · +39 more sites
RecruitingPhase 3NCT07743450
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
Sponsor: Ascletis Pharma (China) Co., Limited
Austin, TX · Brownsville, TX · DeSoto, TX · +81 more sites
RecruitingPhase 2NCT07646587
A Study of WIN378 in Participants With Moderate to Severe COPD (Sirius)
Sponsor: Windward Bio
McKinney, TX · Waxahachie, TX · +6 more sites
RecruitingPhase 3NCT05125302
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
Sponsor: AbbVie
Austin, TX · +122 more sites
RecruitingPhase 1 / Phase 2NCT06783309
CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)
Sponsor: COUR Pharmaceutical Development Company, Inc.
Austin, TX · Dallas, TX · Humble, TX · +42 more sites
RecruitingPhase 3NCT07645924
A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
Sponsor: Kallyope Inc.
Austin, TX · Cypress, TX · +110 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.